Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation. Issue 6 (29th August 2013)

• Record Type: Journal Article
• Authors: Muralidharan, Sujatha; Mandrekar, Pranoti
• Is Part Of: Journal of leukocyte biology. Volume 94:Issue 6(2013)
• Page Start: 1167
• Page End: 1184
• Publication Date: 2013-08-29
• Subjects: PRR signaling -- innate immune response -- oxidative stress -- heat shock -- ER stress -- DNA damage; Leucocytes -- Periodicals; Reticulo-endothelial system -- Periodicals; 571.96
• DOI: 10.1189/jlb.0313153
• Languages: English
• ISSNs: 0741-5400

Abstract

Abstract : Review on the role of cellular stress proteins in innate immune signaling responses during infection and inflammation. Abstract : Extensive research in the past decade has identified innate immune recognition receptors and intracellular signaling pathways that culminate in inflammatory responses. Besides its role in cytoprotection, the importance of cell stress in inflammation and host defense against pathogens is emerging. Recent studies have shown that proteins in cellular stress responses, including the heat shock response, ER stress response, and DNA damage response, interact with and regulate signaling intermediates involved in the activation of innate and adaptive immune responses. The effect of such regulation by cell stress proteins may dictate the inflammatory profile of the immune response during infection and disease. In this review, we describe the regulation of innate immune cell activation by cell stress pathways, present detailed descriptions of the types of stress response proteins and their crosstalk with immune signaling intermediates that are essential in host defense, and illustrate the relevance of these interactions in diseases characteristic of aberrant immune responses, such as chronic inflammatory diseases, autoimmune disorders, and cancer. Understanding the crosstalk between cellular stress proteins and immune signaling may have translational implications for designing more effective regimens to treat immune disorders.